Sepsis & Septic Shock Market in 7MM to Post 7.9% CAGR to...
15 Nov 2017
LONDON – Currently, generic products dominate the sepsis and septic shock market, as the management of such patients chiefly relies upon antibacterial therapy, fluid resuscitation, vasostimulants, antithrombotic agents, steroids, and immunoprot...